Kapvay is indicated for use as add-on therapy to stimulate medications. This formulation of clonidine is indicated for treating patients with ADHD, either as monotherapy or as adjunctive therapy to ...
A Prescription Drug User Fee Act target date of May 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...
Laura E. Knouse is an unpaid clinical consultant for Get Inflow LTD. She is a member of the professional advisory board for Children and Adults with ADHD (CHADD ...